Telehealth patients are scrambling for in-person care amid crackdown on online controlled substances
Catherine was getting nervous about her ADHD prescription. In 2022, the 29-year-old New Yorker had started using Done, a direct-to-consumer telehealth company that treats attention deficit hyperactivity disorder. The medication her provider had prescribed, a stimulant called Vyvanse, was helping her manage distraction so severe that she frequently had car accidents.
Other Articles in this Edition
The link between mental health and ADHD is strong — so why aren’t we paying attention?
Telehealth patients are scrambling for in-person care amid crackdown on online controlled substances
Making Collaboration Work With ADHD
Antipsychotic prescriptions rising among youths